Anton Iliuk

Cdc28 and Cdc14 control stability of the anaphase-promoting complex inhibitor Acm1.

Playing tag with quantitative proteomics.

Quantitative phospho-proteomics based on soluble nanopolymers.

Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase.

In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers.

The tig1 histone deacetylase complex regulates infectious growth in the rice blast fungus Magnaporthe oryzae.

Phosphorylation assay based on multifunctionalized soluble nanopolymer.

Identification of drug targets in vitro and in living cells by soluble-nanopolymer-based proteomics.

Aptamer in bioanalytical applications.

Identifying protein complexes by affinity purification and mass spectrometry analysis in the rice blast fungus.

Functionalized soluble nanopolymers for phosphoproteome analysis.

Regulation of parkin and PINK1 by neddylation.

Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

Chemical visualization of phosphoproteomes on membrane.

Multiplexed quantitation of protein expression and phosphorylation based on functionalized soluble nanopolymers.

Is phosphoproteomics ready for clinical research?

Syk inhibits the activity of protein kinase A by phosphorylating tyrosine 330 of the catalytic subunit.

ArhGAP15, a Rac-specific GTPase-activating protein, plays a dual role in inhibiting small GTPase signaling.

Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.

Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer.

Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.

Global phosphoproteomics of activated B cells using complementary metal ion functionalized soluble nanopolymers.

Universal non-antibody detection of protein phosphorylation using pIMAGO.

Sensitive measurement of total protein phosphorylation level in complex protein samples.

In-Depth Analyses of B Cell Signaling Through Tandem Mass Spectrometry of Phosphopeptides Enriched by PolyMAC.

Multiplexed Imaging of Protein Phosphorylation on Membranes Based on Ti(IV) Functionalized Nanopolymers.

Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation.

Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.

Analytical Pipeline for Discovery and Verification of Glycoproteins from Plasma-Derived Extracellular Vesicles as Breast Cancer Biomarkers.

Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles.

High-Throughput Phosphorylation Screening and Validation through Ti(IV)-Nanopolymer Functionalized Reverse Phase Phosphoprotein Array.

Sequential phosphoproteomics and N-glycoproteomics of plasma-derived extracellular vesicles.

Plasma-Derived Extracellular Vesicle Phosphoproteomics through Chemical Affinity Purification.

Glass Fiber-Supported Hybrid Monolithic Spin Tip for Enrichment of Phosphopeptides from Urinary Extracellular Vesicles.

Profiling Glycoproteins on Functionalized Reverse Phase Protein Array.

Purification and Phosphoproteomic Analysis of Plasma-Derived Extracellular Vesicles.

Proteomics, Phosphoproteomics and Mirna Analysis of Circulating Extracellular Vesicles through Automated and High-Throughput Isolation.

Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tumor microenvironment.

ALCAM: A Novel Surface Marker on EpCAM Circulating Tumor Cells.

Supramolecular Exosome Array for Efficient Capture and In Situ Detection of Protein Biomarkers.

Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles.

Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus.

A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic Cancer.

Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation.

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease.

Isolation and Identification of Plasma Extracellular Vesicles Protein Biomarkers.

Mass spectrometry-based phosphoproteomics in clinical applications.

Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.

One-Pot Analytical Pipeline for Efficient and Sensitive Proteomic Analysis of Extracellular Vesicles.